Activation of postsynaptic Ca(2+) stores modulates glutamate receptor cycling in hippocampal neurons

J Neurophysiol. 2005 Jan;93(1):178-88. doi: 10.1152/jn.00651.2004.

Abstract

We show that activation of postsynaptic inositol 1,4,5-tris-phosphate receptors (IP(3)Rs) with the IP(3)R agonist adenophostin A (AdA) produces large increases in AMPA receptor (AMPAR) excitatory postsynaptic current (EPSC) amplitudes at hippocampal CA1 synapses. Co-perfusion of the Ca(2+) chelator bis-(o-aminophenoxy)-N,N,N',N'-tetraacetic acid strongly inhibited AdA-enhanced increases in EPSC amplitudes. We examined the role of AMPAR insertion/anchoring in basal synaptic transmission. Perfusion of an inhibitor of synaptotagmin-soluble n-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor SNARE-mediated exocytosis depressed basal EPSC amplitudes, whereas a peptide that inhibits GluR2/3 interactions with postsynaptic density-95 (PDZ) domain proteins glutamate receptor interacting protein (GRIP)/protein interacting with C-kinase-1 (PICK1) enhanced basal synaptic transmission. These results suggest that constitutive trafficking and anchoring of AMPARs help maintain basal synaptic transmission. The regulation of postsynaptic AMPAR trafficking involves synaptotagmin-SNARE-mediated vesicle exocytosis and interactions between AMPARs and the PDZ domains in GRIP/PICK1. We show that inhibitors of synaptotagmin-SNARE-mediated exocytosis, or interactions between AMPARs and GRIP/PICK1, attenuated AdA-enhanced increases in EPSC amplitudes. These results suggest that IP(3)R-mediated Ca(2+) release can enhance AMPAR EPSC amplitudes through mechanisms that involve AMPAR-PDZ interactions and/or synaptotagmin-SNARE-mediated receptor trafficking.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Animals
  • Animals, Newborn
  • Calcium / metabolism*
  • Calcium Channel Agonists / pharmacology
  • Calcium-Binding Proteins / chemistry
  • Calcium-Binding Proteins / pharmacology
  • Carrier Proteins / pharmacology
  • Chelating Agents / pharmacology
  • Complement C2 / pharmacology
  • Complement C2a
  • Drug Interactions
  • Egtazic Acid / analogs & derivatives*
  • Egtazic Acid / pharmacology
  • Electric Stimulation
  • Hippocampus / cytology*
  • Hippocampus / physiology
  • In Vitro Techniques
  • Membrane Glycoproteins / chemistry
  • Membrane Glycoproteins / pharmacology
  • Nerve Tissue Proteins / chemistry
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / pharmacology
  • Nerve Tissue Proteins / physiology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurons / physiology
  • Patch-Clamp Techniques / methods
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA / chemistry
  • Receptors, AMPA / metabolism
  • Receptors, Glutamate / metabolism*
  • SNARE Proteins
  • Synapses / drug effects
  • Synapses / metabolism*
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Synaptotagmins
  • Vesicular Transport Proteins / chemistry
  • Vesicular Transport Proteins / pharmacology

Substances

  • Calcium Channel Agonists
  • Calcium-Binding Proteins
  • Carrier Proteins
  • Chelating Agents
  • Complement C2
  • Membrane Glycoproteins
  • Nerve Tissue Proteins
  • Receptors, AMPA
  • Receptors, Glutamate
  • SNARE Proteins
  • Vesicular Transport Proteins
  • postsynaptic density proteins
  • Synaptotagmins
  • adenophostin A
  • Egtazic Acid
  • Complement C2a
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Adenosine
  • Calcium